Victory Capital Management, Inc. 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 11:06 am Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
Victory Capital Management, Inc. | 1,155,516 5.710% |
305,319 (+35.91%) |
Filing |
| 2023-01-31 1:51 pm Sale |
2022-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
Victory Capital Management, Inc. | 850,197 5.050% |
-167 (-0.02%) |
Filing |
| 2022-02-02 09:55 am Unchanged |
2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
Victory Capital Management, Inc. | 850,364 5.830% |
0 (Unchanged) |
Filing |
| 2022-01-04 12:37 pm Sale |
2021-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
Victory Capital Management, Inc. | 850,364 5.830% |
-1,560 (-0.18%) |
Filing |
| 2021-03-08 11:05 am Purchase |
2021-02-28 | 13G | Regulus Therapeutics Inc. RGLS |
Victory Capital Management, Inc. | 851,924 12.730% |
851,924 (New Position) |
Filing |